In Newsweek, Sharon Begley writes that "second thoughts" about personalized medicine "are clearly setting in" as a result of studies showing that adding genetic risk factors to traditional risk factors does not improve the ability to predict whether someone develops that disease. "The revolution in using DNA to read people's medical future is turning out to be more hype than hope," Begley writes.